RADX

Radiopharm Theranostics

RADX·75041J101·US·ADR·Healthcare - Biotechnology-13D/G

RADX (Radiopharm Theranostics) is held by 4 institutional investors as of Q1 2026. Largest holders: HSBC HOLDINGS PLC ($264,513), PNC FINANCIAL SERVICES GROUP, INC. ($68,800), UBS Group AG ($12,900). Net institutional sentiment: Bearish.

4
Holders
(1 Elite)
$346,732
Total Value
17% (6)
Consensus
1 buying - 5 selling
13F: Insider & Congress:
RADX

Smart Money Verdict

View all
Held by 4 funds
1 elite

Who's Trading

ActivistJPMORGAN CHASE & CO.JPMORGAN CHASE & CO.4.0%Jan 16, 2026
ActivistRPRegal Partners Holdings Pty Limited9.1%Jan 8, 2026

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
61,372(-68.0%)$264,5130.0%-45.74%
0
Unchanged
16,000$68,8000.0%-46.77%
0
Decreased
3,000(-79.0%)$12,9000.0%-41.01%
0
Increased
121(+1916.7%)$5190.0%-42.56%
12
Exited
0(-100.0%)$75,5280.0%-5.81%
0
Exited
0(-100.0%)$53,6880.0%-5.81%
0
Exited
0(-100.0%)$76,0000.0%-5.81%
0
RADXRADXRadiopharm Theranostics

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used